Tumorigenesis is a multifactorial and complex process involving multiple oncogenes and resulting in cancerous cells with specific proliferation capabilities as well as particular sensitivity to given cytotoxic agents. In other words, every cancer is unique and efficient therapy requires extensive knowledge of its characteristics.

Traditional diagnostic information (age, tumor localization and size, histology and immuno-histochemistry) provides oncologists with limited guidance to optimize treatment options.

Molecular diagnostics, based on knowledge of the pathways involved in cancer initiation and development, now have the potential to classify the disease, measure its degree of aggressiveness and indicate which drug should preferably be used. Some of these tests can also be used during follow-up to monitor treatment efficacy.

IPSOGEN delivers tools to directly measure cancer biomarkersthat signal genetic alterations at the origin of the disease, delivering unrivalled sensitivity and reliability.